Dumadaug, Eriberto F.
HRN: 21-56-18 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/30/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
10/30/2024
11/06/2024
IV
600MG
Q8
DM FOOT
Waiting Final Action
Indication: Empiric Type of Infection: BloodstreamBone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes